Post-Conference Perspectives: CD19-directed CAR-T Cell Therapy in Lymphomas - Episode 4
Experts discuss data on a novel form of CAR T-cell therapy, rapcabtagene autoleucel, for the second-line treatment of R/R LBCL with a faster manufacturing process.